AZACITIDINE FOR INJECTION DIN 02507668
Health Canada record
| Active ingredient(s) | AZACITIDINE 100 MG |
|---|---|
| Dosage form | Powder For Suspension |
| Route | Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01BC07 AZACITIDINE |
| Original market date | 24-Feb-2022 |
| Current status date | 24-Feb-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
Hikma Canada Limited — licence 3-002579, currently licensed, last inspection rating C (2022-04-26).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing AZACITIDINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02529599 | AZACITIDINE FOR INJECTION | SANDOZ CANADA INCORPORATED | Powder For Suspension | AZACITIDINE 100 MG | Marketed |
| 02534029 | AZACITIDINE FOR INJECTION | STERIMAX INC | Powder For Suspension | AZACITIDINE 100 MG | Approved |
| 02571102 | AZACITIDINE FOR INJECTION | APOTEX INC | Powder For Suspension | AZACITIDINE 100 MG | Approved |
| 02564998 | AZACITIDINE FOR INJECTION | MSN LABS CANADA INC. | Powder For Suspension | AZACITIDINE 100 MG | Approved |
| 02558815 | AZACITIDINE FOR INJECTION | DR REDDY'S LABORATORIES LTD | Powder For Suspension | AZACITIDINE 150 MG | Approved |
| 02505177 | AZACITIDINE FOR INJECTION | FRESENIUS KABI CANADA LTD | Powder For Suspension | AZACITIDINE 100 MG | Marketed |
| 02462826 | AZACITIDINE FOR INJECTION | DR REDDY'S LABORATORIES LTD | Powder For Suspension | AZACITIDINE 100 MG | Marketed |
| 02534037 | AZACITIDINE FOR INJECTION | STERIMAX INC | Powder For Suspension | AZACITIDINE 150 MG | Approved |
| 02510200 | ONUREG | BRISTOL-MYERS SQUIBB CANADA | Tablet | AZACITIDINE 300 MG | Marketed |
| 02510197 | ONUREG | BRISTOL-MYERS SQUIBB CANADA | Tablet | AZACITIDINE 200 MG | Marketed |
| 02336707 | VIDAZA | BRISTOL-MYERS SQUIBB CANADA | Powder For Suspension | AZACITIDINE 100 MG | Marketed |
| 02501791 | AZACITIDINE FOR INJECTION | JAMP PHARMA CORPORATION | Powder For Suspension | AZACITIDINE 100 MG | Dormant |
| 02480220 | NAT-AZACITIDINE | NATCO PHARMA (CANADA) INC | Powder For Suspension | AZACITIDINE 100 MG | Cancelled Pre Market |
| 02532085 | PMS-AZACITIDINE FOR INJECTION | PHARMASCIENCE INC | Powder For Suspension | AZACITIDINE 100 MG | Cancelled Pre Market |
| 02463199 | REDDY-AZACITIDINE | DR REDDY'S LABORATORIES LTD | Powder For Suspension | AZACITIDINE 100 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 24592 | 2020-11-09 | Abbreviated New Drug Submission (ANDS) |
International API supply for AZACITIDINE
19 active FDA Drug Master Files.
Request a quote for AZACITIDINE FOR INJECTION